Survival after standard or oncoplastic breast-conserving surgery versus mastectomy for breast cancer
BJS Open · 04.03.2025 · 9 (2)
DOI: 10.1093/bjsopen/zraf002 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift BJS Open, online erschienen am 19.03.2025. Verfasst von Mhairi Mactier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Wohl Cancer Research Centre, College of Medicine and Veterinary Science, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Segmental, Mastectomy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Recent evidence suggests a survival advantage after breast-conserving surgery compared with mastectomy. Previous studies have compared survival outcomes after standard breast-conserving surgery, but no studies have compared survival outcomes after oncoplastic breast-conserving surgery. The aim of this study was to compare survival outcomes after breast-conserving surgery + radiotherapy (and an oncoplastic breast-conserving surgery + radiotherapy subgroup) with those after mastectomy ± radiotherapy.
Methods
Patients diagnosed with primary invasive breast cancer between 1 January 2010 and 31 December 2019 were identified from a prospectively maintained National Cancer Registry. Overall survival and breast cancer-specific survival outcomes were analysed using Kaplan–Meier analysis and Cox regression analysis adjusting for patient demographics, tumour characteristics, and treatment adjuncts.
Results
A total of 14 182 patients were eligible (8537 patients underwent standard breast-conserving surgery + radiotherapy, 360 patients underwent oncoplastic breast-conserving surgery + radiotherapy, 2953 patients underwent mastectomy + radiotherapy, and 2332 patients underwent mastectomy − radiotherapy). The median follow-up was 7.27 (range 0.2–13.6) years. Superior 10-year survival was observed after breast-conserving surgery + radiotherapy (overall survival: 81.2%; breast cancer-specific survival: 93.3%) compared with mastectomy + radiotherapy (overall survival: 63.4%; breast cancer-specific survival: 75.9%) and mastectomy − radiotherapy (overall survival: 63.1%; breast cancer-specific survival: 87.5%). Ten-year overall survival and breast cancer-specific survival after oncoplastic breast-conserving surgery + radiotherapy were 86.1% and 90.2% respectively. After adjusted analysis, breast-conserving surgery + radiotherapy was associated with superior survival outcomes compared with mastectomy + radiotherapy (overall survival: HR 1.34 (95% c.i. 1.20 to 1.51); breast cancer-specific survival: HR 1.62 (95% c.i. 1.38 to 1.90)) and mastectomy − radiotherapy (overall survival: HR 1.57 (95% c.i. 1.41 to 1.75); breast cancer-specific survival: HR 1.70 (95% c.i. 1.41 to 2.05)). Similar survival outcomes were observed amongst patients treated with oncoplastic breast-conserving surgery + radiotherapy compared with mastectomy + radiotherapy (overall survival: HR 1.72 (95% c.i. 1.62 to 2.55); breast cancer-specific survival: HR 1.74 (95% c.i. 1.06 to 2.86)) and mastectomy − radiotherapy (overall survival: HR 2.21 (95% c.i. 1.49 to 3.27); breast cancer-specific survival: HR 1.89 (95% c.i. 1.13 to 3.14)).
Conclusion
Breast-conserving surgery + radiotherapy and oncoplastic breast-conserving surgery + radiotherapy are associated with superior overall survival and breast cancer-specific survival compared with mastectomy ± radiotherapy. The findings should inform discussion of surgical treatment options for patients with breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Wolfson Wohl Cancer Research Centre, College of Medicine and Veterinary Science, University of Glasgow, Glasgow, UK.
- General Surgery Department, Golden Jubilee National Hospital, Clydebank, UK.
- General Surgery Department, Gartnavel General Hospital, Glasgow, UK.
- General Surgery Department, Royal Alexandria Hospital, Paisley, UK.
ORCID-Profile: Mhairi Mactier
Zitieren
APA
Mactier, M., Mansell, J., Arthur, L., Doughty, J., & Romics, L. (2025). Survival after standard or oncoplastic breast-conserving surgery versus mastectomy for breast cancer. BJS Open, 9(2). https://doi.org/10.1093/bjsopen/zraf002
Vancouver
Mactier M, Mansell J, Arthur L, Doughty J, Romics L. Survival after standard or oncoplastic breast-conserving surgery versus mastectomy for breast cancer. BJS Open. 2025;9(2). doi:10.1093/bjsopen/zraf002
BibTeX
@article{Mactier2025,
author = {Mactier, Mhairi and Mansell, James and Arthur, Laura and Doughty, Julie and Romics, Laszlo},
title = {Survival after standard or oncoplastic breast-conserving surgery versus mastectomy for breast cancer},
journal = {BJS Open},
year = {2025},
volume = {9},
number = {2},
doi = {10.1093/bjsopen/zraf002}
}
EUVIMED